                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
       COLORADO STATE UNIVERSITY RESEARCH FOUNDATION
 
<120>  TREATMENT METHODS USING PEPTIDE-BASED INHIBITORS OF THE 
       STAT3-IL10 PATHWAY

<130>  722809

<150>  US 62/100763
<151>  2015-01-07

<160>  90    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein x can be any amino acid

<400>  1

Xaa Val Leu Xaa Phe Xaa Lys 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2

Ser Val Leu Leu Phe Lys Lys 
1               5           


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Leu modified with palmitoyl group

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Lys modified with an amino group

<400>  3

Xaa Tyr Val Arg Arg Arg Lys Lys Leu Pro Ser Val Leu Leu Phe Lys 
1               5                   10                  15      


Xaa 
    


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Ser modified with amino group

<400>  4

Xaa Lys Leu Pro Ser Val Leu Leu Phe Lys Lys Pro Xaa 
1               5                   10              


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ser modified with acetyl group

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Epsilon-palmitoyl modified lysine

<400>  5

Xaa Pro Lys Lys Phe Leu Leu Val Ser Pro Leu Lys Xaa 
1               5                   10              


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lys modified with acetyl group

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Epsilon-palmitoyl modified lysine

<400>  6

Xaa Lys Phe Leu Leu Val Ser Pro Leu Lys Xaa 
1               5                   10      


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Pro modified with acetyl group

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Epsilon-palmitoyl modified lysine

<400>  7

Xaa Lys Lys Phe Leu Leu Val Ser Pro Leu Lys Xaa 
1               5                   10          


<210>  8
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  wherein x can be any amino acid

<400>  8

Leu His Gly Ser Thr Xaa Ser Gly Phe Gly Ser Xaa Lys Pro Ser Leu 
1               5                   10                  15      


Gln Xaa 
        


<210>  9
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein x is Asp or Asn

<400>  9

Leu His Gly Ser Thr Xaa Ser Gly Phe Gly Ser Thr Lys Pro Ser Leu 
1               5                   10                  15      


Gln Thr 
        


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Leu modified with palmitoyl group

<400>  10

Xaa His Gly Ser Thr Asp Ser Gly Phe Gly Ser Thr Lys Pro Ser Leu 
1               5                   10                  15      


Gln Thr 
        


<210>  11
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Glu modified with acetyl group

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Epsilon-palmitoyl modified lysine

<400>  11

Xaa Glu Thr Gln Leu Ser Pro Lys Thr Ser Gly Phe Gly Ser Asp Thr 
1               5                   10                  15      


Ser Gly His Leu Xaa 
            20      


<210>  12
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Glu modified with acetyl group

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  Epsilon-palmitoyl modified lysine

<400>  12

Xaa Thr Gln Leu Ser Pro Lys Thr Ser Gly Phe Gly Ser Asp Thr Ser 
1               5                   10                  15      


Gly His Leu Xaa 
            20  


<210>  13
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Thr modified with acetyl group

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Epsilon-palmitoyl modified lysine

<400>  13

Xaa Gln Leu Ser Pro Lys Thr Ser Gly Phe Gly Ser Asp Thr Ser Gly 
1               5                   10                  15      


His Leu Xaa 
            


<210>  14
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Leu modified with amino group

<400>  14

Xaa Thr Gln Leu Ser Pro Lys Thr Ser Gly Phe Gly Ser Asp Thr Ser 
1               5                   10                  15      


Gly His Xaa 
            


<210>  15
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  Leu modified with amino group

<400>  15

Xaa Glu Glu Thr Gln Leu Ser Pro Lys Thr Ser Gly Phe Gly Ser Asp 
1               5                   10                  15      


Thr Ser Gly His Xaa 
            20      


<210>  16
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (19)..(19)
<223>  Leu modified with amino group

<400>  16

Xaa Thr Gln Leu Ser Pro Lys Thr Ser Gly Phe Gly Ser Asn Thr Ser 
1               5                   10                  15      


Gly His Xaa 
            


<210>  17
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  17

Thr Asp Ser Gly Ile Cys Leu Gln 
1               5               


<210>  18
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  Cyclic peptide with a disulfide bond bridging the Cys residues

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<400>  18

Xaa Thr Cys Gly Asp Asn Thr Asp Ser Gly Ile Cys Leu Gln 
1               5                   10                  


<210>  19
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  Cyclic peptide with a disulfide bond bridging the Cys residues

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<400>  19

Xaa Ser Cys Ser Ser Gly Ser Ser Asn Ser Thr Asp Ser Gly Ile Cys 
1               5                   10                  15      


Leu Gln 
        


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein x can be any amino acid

<400>  20

Phe Xaa Gly Tyr Xaa Xaa Gln Thr Arg 
1               5                   


<210>  21
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  wherein x can be any amino acid

<400>  21

Leu His Gly Ser Thr Xaa Ser Gly Phe Gly Ser Xaa Lys 
1               5                   10              


<210>  22
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Arg modified with amino group

<400>  22

Xaa Phe Gln Gly Tyr Leu Arg Gln Thr Xaa 
1               5                   10  


<210>  23
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ala modified with palmitoyl group

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Arg modified with amino group

<400>  23

Xaa Phe Gln Gly Tyr Leu Arg Gln Thr Xaa 
1               5                   10  


<210>  24
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Arg modified with acetyl group

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Epsilon-palmitoyl modified lysine

<400>  24

Xaa Thr Gln Arg Leu Tyr Gly Gln Phe Xaa 
1               5                   10  


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  wherein x can be any amino acid

<400>  25

Ala Xaa Gly Tyr Leu Lys Gln 
1               5           


<210>  26
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Gln modified with amino group

<400>  26

Xaa Pro Pro Ala Leu Ala Lys Gly Tyr Leu Lys Xaa 
1               5                   10          


<210>  27
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Glu modified with amino group

<400>  27

Xaa Pro Pro Ala Leu Ala Lys Gly Tyr Leu Lys Gln Xaa 
1               5                   10              


<210>  28
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Gln modified with amino group

<400>  28

Xaa Ala Lys Gly Tyr Leu Lys Xaa 
1               5               


<210>  29
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Leu modified with palmitoyl group

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Gln modified with amino group

<400>  29

Xaa Ala Lys Gly Tyr Leu Lys Xaa 
1               5               


<210>  30
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  30

Leu Val Thr Leu Pro Leu Ile Ser Ser Leu 
1               5                   10  


<210>  31
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Glu modified with amino group

<400>  31

Xaa Leu Val Thr Leu Pro Leu Ile Ser Ser Leu Gln Ser Ser Xaa 
1               5                   10                  15  


<210>  32
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Gln modified with amino group

<400>  32

Xaa Leu Val Thr Leu Pro Leu Ile Ser Ser Leu Xaa 
1               5                   10          


<210>  33
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Leu modified with amino group

<400>  33

Xaa Leu Val Thr Leu Pro Leu Ile Ser Ser Xaa 
1               5                   10      


<210>  34
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Epsilon-palmitoyl modified lysine

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Leu modified with amino group

<400>  34

Xaa Asn Leu Val Thr Leu Pro Leu Ile Ser Ser Xaa 
1               5                   10          


<210>  35
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Leu modified with palmitoyl group

<400>  35

Xaa His Gly Ser Thr Asp Ser Gly Phe Gly Ser Thr Lys 
1               5                   10              


<210>  36
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  wherein x can be any amino acid

<400>  36

Pro Xaa His Leu Lys Glu Xaa Leu 
1               5               


<210>  37
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  37

Ser Glu Phe Asp Ile Phe Ile Asn Tyr Ile Glu Ala Tyr 
1               5                   10              


<210>  38
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tyr modified with Ac-C(Fluo)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  wherein x is norleucine

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  wherein x is norleucine

<220>
<221>  MISC_FEATURE
<222>  (20)..(20)
<223>  wherein x is norleucine

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  Asn modified with amino group

<400>  38

Xaa Lys Ala Xaa Ser Glu Phe Asp Ile Phe Ile Asn Tyr Ile Glu Ala 
1               5                   10                  15      


Tyr Xaa Thr Xaa Lys Ile Arg Xaa 
            20                  


<210>  39
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(7)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  wherein x can be any amino acid

<400>  39

Xaa Thr Xaa Tyr Leu Xaa Xaa Leu His Xaa Leu Xaa 
1               5                   10          


<210>  40
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein x can be any amino acid

<400>  40

Xaa Thr Arg Tyr Leu Xaa Gln Leu His Lys Leu Tyr 
1               5                   10          


<210>  41
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(7)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (12)..(13)
<223>  wherein x can be any amino acid

<400>  41

Xaa Thr Xaa Tyr Leu Xaa Xaa Leu His Xaa Leu Xaa Xaa 
1               5                   10              


<210>  42
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  wherein x can be any amino acid

<400>  42

Xaa Thr Arg Tyr Leu Xaa Gln Leu His Lys Leu Tyr Xaa 
1               5                   10              


<210>  43
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa can be any amino acid and may or may not be present

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(8)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  wherein x can be any amino acid

<400>  43

Xaa Xaa Leu Xaa His Leu Xaa Xaa Leu Tyr Xaa Thr Xaa 
1               5                   10              


<210>  44
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa can be any amino acid and may or may not be present

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  wherein x can be any amino acid

<400>  44

Xaa Tyr Leu Lys His Leu Gln Xaa Leu Tyr Arg Thr Xaa 
1               5                   10              


<210>  45
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(2)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (7)..(8)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  wherein x can be any amino acid

<400>  45

Xaa Xaa Leu Xaa His Leu Xaa Xaa Leu Tyr Xaa Thr Xaa 
1               5                   10              


<210>  46
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  wherein x can be any amino acid

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  wherein x can be any amino acid

<400>  46

Xaa Tyr Leu Lys His Leu Gln Xaa Leu Tyr Arg Thr Xaa 
1               5                   10              


<210>  47
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  47

Leu Asp Thr Arg Tyr Leu Glu Gln Leu His Gln Leu Tyr Ser 
1               5                   10                  


<210>  48
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  48

Asp Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Tyr Ser 
1               5                   10              


<210>  49
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  49

Leu Asp Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Tyr Ser 
1               5                   10                  


<210>  50
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  X is 4-cyano phenylalanine

<400>  50

Asp Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Xaa Ser 
1               5                   10              


<210>  51
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  51

Asp Thr Lys Tyr Leu Glu Gln Leu His Lys Leu Tyr Ser 
1               5                   10              


<210>  52
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  52

Asp Thr Arg Tyr Leu Gln Glu Leu His Lys Leu Tyr Ser 
1               5                   10              


<210>  53
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is Diaminobutyric acid

<400>  53

Asp Thr Arg Tyr Leu Glu Gln Leu His Xaa Leu Tyr Ser 
1               5                   10              


<210>  54
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  54

Ala Gln Trp Asn Gln Leu Gln Gln Leu Asp Thr Arg Tyr Leu Glu Gln 
1               5                   10                  15      


Leu His Gln Leu Tyr Ser 
            20          


<210>  55
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  55

Leu Asp Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Tyr 
1               5                   10              


<210>  56
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  56

Asp Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Tyr 
1               5                   10          


<210>  57
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp modified with acetyl group

<400>  57

Xaa Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Tyr 
1               5                   10          


<210>  58
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  X is Diaminobutyric acid.

<400>  58

Leu Asp Thr Arg Tyr Leu Glu Gln Leu His Xaa Leu Tyr 
1               5                   10              


<210>  59
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  X is Diaminobutyric acid.

<400>  59

Asp Thr Arg Tyr Leu Glu Gln Leu His Xaa Leu Tyr 
1               5                   10          


<210>  60
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  X is Diaminobutyric acid.

<400>  60

Leu Asp Thr Lys Tyr Leu Glu Gln Leu His Xaa Leu Tyr 
1               5                   10              


<210>  61
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp modified with acetyl group

<400>  61

Xaa Thr Arg Tyr Leu Glu Gln Leu His Ala Leu Tyr 
1               5                   10          


<210>  62
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp modified with acetyl group

<400>  62

Xaa Thr Arg Tyr Leu Glu Gln Leu His Glu Leu Tyr 
1               5                   10          


<210>  63
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ala modified with acetyl group

<400>  63

Xaa Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Tyr 
1               5                   10          


<210>  64
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Asp modified with palmitoyl group

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Epsilon-palmitoyl modified lysine

<400>  64

Xaa Thr Lys Tyr Leu Glu Gln Leu His Lys Leu Tyr Lys Xaa 
1               5                   10                  


<210>  65
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  65

Leu Asp Thr Arg Tyr Leu Glu Gln Leu His Lys Leu Tyr 
1               5                   10              


<210>  66
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ile modified with palmitoyl group

<400>  66

Xaa Gln Arg Tyr Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp 
1               5                   10                  15  


<210>  67
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ile modified with palmitoyl group

<400>  67

Xaa Gln Lys Tyr Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp 
1               5                   10                  15  


<210>  68
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Gln modified with palmitoyl group

<400>  68

Xaa Arg Tyr Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp 
1               5                   10                  


<210>  69
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Arg modified with palmitoyl group

<400>  69

Xaa Tyr Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp 
1               5                   10              


<210>  70
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Gln modified with palmitoyl group

<400>  70

Xaa Tyr Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp 
1               5                   10              


<210>  71
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lys modified with palmitoyl group

<400>  71

Xaa Tyr Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp 
1               5                   10              


<210>  72
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ile modified with palmitoyl group

<400>  72

Xaa Gln Arg Tyr Leu Lys His Leu Gln Gln Leu Tyr Arg Thr Asp 
1               5                   10                  15  


<210>  73
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Ile modified with palmitoyl group

<400>  73

Xaa Gln Arg Tyr Leu Lys His Leu Gln Gln Leu Tyr Arg Thr Asn 
1               5                   10                  15  


<210>  74
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tyr modified with palmitoyl group

<400>  74

Xaa Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp 
1               5                   10          


<210>  75
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Gln modified with palmitoyl group

<400>  75

Xaa Arg Tyr Leu Lys His Leu Gln Glu Leu Tyr Arg Thr Asp Leu 
1               5                   10                  15  


<210>  76
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<223>  All the amino acids are D-amino acids

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Tyr modified with palmitoyl group

<400>  76

Xaa Leu Lys His Leu Gln Gln Leu Tyr Arg Thr Asn 
1               5                   10          


<210>  77
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  77

Arg Gln Ile Lys 
1               


<210>  78
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  78

Lys Gln Ile Lys 
1               


<210>  79
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  79
gctcttactg actggcatga g                                                 21


<210>  80
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  80
caataccatt gacctgccga t                                                 21


<210>  81
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  81
aataccattg acctgccgat                                                   20


<210>  82
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  82
agcgactcaa actgccct                                                     18


<210>  83
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  83
atgaacgcta cacactgcat c                                                 21


<210>  84
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  84
ccatcctttt gccagttcct c                                                 21


<210>  85
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  85
gttctcagcc caacaataca aga                                               23


<210>  86
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  86
gtggacgggt cgatgtcac                                                    19


<210>  87
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  87
cagaagaatg gaagagtcag                                                   20


<210>  88
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  88
cagatatgca gggagtcacc                                                   20


<210>  89
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  89
gtaacccgtt gaaccccatt                                                   20


<210>  90
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  90
ccatccaatc ggtagtagcg                                                   20


